Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franck Morschhauser

Showing results (31-40 of 315) with videos related to

Pageof 32
Sort By:
Leukemia & Lymphoma|May 18, 2016
Panobinostat consolidation in patients with Hodgkin lymphoma at risk for relapse after high dose chemotherapy and autologous stem cell transplant: final results after early trial discontinuationBastian von Tresckow, Franck Morschhauser, Jeffrey Szer, et al.
Haematologica|December 15, 2015
Rationale for optimal obinutuzumab/GA101 dosing regimen in B-cell non-Hodgkin lymphomaGuillaume Cartron, Florence Hourcade-Potelleret, Franck Morschhauser, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 16, 2019
<sup>18</sup>F-FDG PET Dissemination Features in Diffuse Large B-Cell Lymphoma Are Predictive of OutcomeAnne-Ségolène Cottereau, Christophe Nioche, Anne-Sophie Dirand, et al.
Pathology, Research and Practice|July 25, 2020
CXCL13 is expressed in various haematological disorders other than angioimmunoblastic T-cell lymphomaSantiago Gimenez de Mestral, Romain Dubois, Jean-Baptiste Gibier, et al.
Journal of Assisted Reproduction and Genetics|July 16, 2014
Detection of non-Hodgkin's lymphoma in ovarian cortex pieces during the process of cryopreservationHéloïse Gronier, Louis Terriou, Geoffroy Robin, et al.
Leukemia|December 13, 2019
Long-term follow-up of patients with mantle cell lymphoma (MCL) treated with the selective Bruton's tyrosine kinase inhibitor tirabrutinib (GS/ONO-4059)Simon A Rule, Guillaume Cartron, Christopher Fegan, et al.
Leukemia & Lymphoma|April 6, 2011
Quality of life in 269 patients with poor-risk diffuse large B-cell lymphoma treated with rituximab versus observation after autologous stem cell transplantNatacha Heutte, Corinne Haioun, Pierre Feugier, et al.
Leukemia & Lymphoma|February 16, 2013
Clinical experience of bendamustine in relapsed or refractory Hodgkin lymphoma: a retrospective analysis of the French compassionate use program in 28 patientsHervé Ghesquières, Aspasia Stamatoullas, Olivier Casasnovas, et al.
Hemasphere|October 16, 2020
Controversies in the Treatment of Peripheral T-cell LymphomaEmmanuel Bachy, Alessandro Broccoli, Claire Dearden, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 10, 2023
Tumor Location Relative to the Spleen Is a Prognostic Factor in Lymphoma Patients: A Demonstration from the REMARC TrialKibrom B Girum, Anne-Ségolène Cottereau, Laetitia Vercellino, et al.
Pageof 32

Showing results (31-40 of 315) with videos related to

Sort By:
Pageof 32
Leukemia & Lymphoma|May 18, 2016
Panobinostat consolidation in patients with Hodgkin lymphoma at risk for relapse after high dose chemotherapy and autologous stem cell transplant: final results after early trial discontinuationBastian von Tresckow, Franck Morschhauser, Jeffrey Szer, et al.
Haematologica|December 15, 2015
Rationale for optimal obinutuzumab/GA101 dosing regimen in B-cell non-Hodgkin lymphomaGuillaume Cartron, Florence Hourcade-Potelleret, Franck Morschhauser, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 16, 2019
<sup>18</sup>F-FDG PET Dissemination Features in Diffuse Large B-Cell Lymphoma Are Predictive of OutcomeAnne-Ségolène Cottereau, Christophe Nioche, Anne-Sophie Dirand, et al.
Pathology, Research and Practice|July 25, 2020
CXCL13 is expressed in various haematological disorders other than angioimmunoblastic T-cell lymphomaSantiago Gimenez de Mestral, Romain Dubois, Jean-Baptiste Gibier, et al.
Journal of Assisted Reproduction and Genetics|July 16, 2014
Detection of non-Hodgkin's lymphoma in ovarian cortex pieces during the process of cryopreservationHéloïse Gronier, Louis Terriou, Geoffroy Robin, et al.
Leukemia|December 13, 2019
Long-term follow-up of patients with mantle cell lymphoma (MCL) treated with the selective Bruton's tyrosine kinase inhibitor tirabrutinib (GS/ONO-4059)Simon A Rule, Guillaume Cartron, Christopher Fegan, et al.
Leukemia & Lymphoma|April 6, 2011
Quality of life in 269 patients with poor-risk diffuse large B-cell lymphoma treated with rituximab versus observation after autologous stem cell transplantNatacha Heutte, Corinne Haioun, Pierre Feugier, et al.
Leukemia & Lymphoma|February 16, 2013
Clinical experience of bendamustine in relapsed or refractory Hodgkin lymphoma: a retrospective analysis of the French compassionate use program in 28 patientsHervé Ghesquières, Aspasia Stamatoullas, Olivier Casasnovas, et al.
Hemasphere|October 16, 2020
Controversies in the Treatment of Peripheral T-cell LymphomaEmmanuel Bachy, Alessandro Broccoli, Claire Dearden, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 10, 2023
Tumor Location Relative to the Spleen Is a Prognostic Factor in Lymphoma Patients: A Demonstration from the REMARC TrialKibrom B Girum, Anne-Ségolène Cottereau, Laetitia Vercellino, et al.
Pageof 32